Sam Goldberger
Managing Partner at Ambit Health Ventures
Greater Boston
Overview
Work Experience
Member Board of Directors
2023 - Current
SurgiBox develops an operating room in a backpack system that makes surgery safer for patients and providers at any time and any place.
Raised $3,525,000.00 from Medical Technology Enterprise Consortium, TechConnect World Innovation Conference & Expo and MassChallenge.
Managing Partner and Co-Founder
2020
Ambit Health Ventures is a boutique healthcare innovation venture capital firm focused on investments in early-stage digital health firms. Our leaders have extensive experience in these sectors. Our aim is to improve healthcare through our portfolio companies’ innovation while achieving financial gain for our investors.
Ambit Health Ventures is a healthcare venture capital firm that focuses on investments in early-stage digital health and MedTech firms.
Member Board of Directors
2023
Clinical stage, novel technologies for managing Glaucoma
Raised $6,100,000.00 from Sophia Innovation Capital, Ambit Health Ventures, Stanford University, WS Investments, Graphene Ventures, Plaisance Capital Management, 3E Bioventures and Boutique Venture Partners.
Member Board of Directors
2022
SOAP's patented, clinically validated, AI powered patient intake combines early disease risk and symptom assessment to improve diagnosis
Raised $3,400,000.00 from Ambit Health Ventures, Mayo Clinic Platform, Jumpstart Foundry and Right Side Capital Management.
Member Board Of Directors
2021
Board Observer, BRAINBox Solutions, Inc
2021
BRAINBox provides objective evidence of injury and prediction of patient recovery.
Raised $39,502,735.00 from Genoa Ventures.
Board Observer, Smartlens
2021 - 2022
Clinical stage, novel technologies for managing Glaucoma
Raised $6,100,000.00 from Sophia Innovation Capital, Ambit Health Ventures, Stanford University, WS Investments, Graphene Ventures, Plaisance Capital Management, 3E Bioventures and Boutique Venture Partners.
Senior Clinical Monitor and Strategic Advisor
2016 - 2021
Privo Technologies is a development-stage biotechnology company located just outside Boston, MA.
Raised $5,684,934.00 from National Cancer Institute, National Institute of Dental and Craniofacial Research (NIDCR), National Science Foundation and MassChallenge.
CEO
2018 - 2020
Sourced, performed due diligence, and invested in early stage healthcare companies.
CEO
2016 - 2018
CEO of operating company for a PE backed ophthalmology and eyecare roll-up.
Education
Bachelor’s Degree
1979 - 1982
Master’s Degree
2015 - 2016
Fellowship
1990 - 1991
Resident
1987 - 1990
Doctor of Medicine (M.D.)
1982 - 1986